Perceived HIV Risk Low Among People Who Inject Drugs
In general, many people who inject drugs perceive themselves to be at a low risk for HIV despite having indications for pre-exposure prophylaxis use.
Read More
HIV/AIDS
PrEP Use Increased From 2013 to 2023
The annual number of PrEP users increased in the United States from 10,281 in 2013 to 505,730 in 2023, primarily in oral formulations.
Read More
Addressing Stigma Alone May Not Improve PrEP Use in Black MSM
In a study of PrEP use in Black sexual minority men, PrEP stigma was associated with a lower likelihood of current PrEP use in all models examined.
Read More
Policies About Late-Career Physicians Are Considered Successful
MONDAY, Nov. 4, 2024 (HealthDay News) — Institutional leaders consider policies about...
Read More
FDA Appoints New Head of Medical Devices
WEDNESDAY, Oct. 23, 2024 (HealthDay News) — The U.S. Food and Drug Administration announced...
Read More
Preexposure Prophylaxis Use Increased in Recent Years
MONDAY, Oct. 21, 2024 (HealthDay News) — Preexposure prophylaxis (PrEP) use increased...
Read More
Metabolic Risk Contributes to Diabetes Onset in People With HIV
MONDAY, Oct. 7, 2024 (HealthDay News) — For people with HIV (PWH) with low-to-moderate...
Read More
Hep C Reinfection Observed in MSM With HIV From 2000 to 2018
Among MSM with HIV who previously cleared HCV, the incidence rate of HCV reinfection was 4.7 per 100 person-years.
Read More
Twice-Yearly Injection Cuts HIV Risk by 96%, But Will Cost Cut Access?
THURSDAY, Sept. 12, 2024 (HealthDay News) — It could be a real breakthrough for people at...
Read More
Kidney and Liver Transplants Less Common in Patients With HIV
While patients with HIV are eligible for kidney and liver transplants, these procedures are uncommon in this patient population.
Read More
Team-Based Documentation Can Increase Visit Volume, Cut Documentation Time
TUESDAY, Aug. 27, 2024 (HealthDay News) — Physicians who adopt team-based documentation,...
Read More
Hep C Reinfection Observed in HIV-Positive Men Who Have Sex With Men
THURSDAY, Aug. 8, 2024 (HealthDay News) — The incidence rate of hepatitis C virus (HCV)...
Read More
Abacavir Use Linked to Increased Incidence of MACE
THURSDAY, Aug. 8, 2024 (HealthDay News) — For patients with HIV in the Randomized Trial to...
Read More
Long-Acting Early Viral Inhibition Described in Context of Long-Acting Injectable Cabotegravir
MONDAY, July 29, 2024 (HealthDay News) — In a research letter published online July 24 in...
Read More
Behavioral Pain Self-Management Intervention Effective for Chronic Pain With HIV
WEDNESDAY, July 24, 2024 (HealthDay News) — A behavioral pain self-management intervention...
Read More
Mean Cost of Bringing New Drug to U.S. Market Is $879.3 Million
TUESDAY, July 2, 2024 (HealthDay News) — The mean cost of developing a new drug for the U.S....
Read More
Twice-a-Year Lenacapavir Injection Gives Women 100% Protection Against HIV
Just two injections a year of a new HIV drug protected young women in Africa from infection with...
Read More
Mailed HIV Self-Tests Increase Testing Among Untested and Those Not Tested in Past Year
Mailed HIV-self tests (HIVSTs) can increase testing among persons who have never received testing...
Read More
Adverse Effects of Medical Treatment Increasing Worldwide
WEDNESDAY, June 12, 2024 (HealthDay News) — The burden of adverse effects of medical...
Read More
2007 to 2019 Saw Increase in Inflation-Adjusted Health Care Spending
WEDNESDAY, May 29, 2024 (HealthDay News) — From 2007 to 2019, there was an increase in...
Read More